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S1. Detailed information about participants 
Here, we detail the inclusion/exclusion criteria for recruitment and information about 
medications. Those with lifetime psychotic disorders, substance dependence, bipolar disorder or 
ADHD were excluded, in addition to those with hoarding as a primary symptom. We allowed 
comorbid anxiety disorders, dysthymic disorder, depressive disorder not otherwise specified, and 
major depressive disorder with ADIS-IV clinical significance rating score < 6. Thirty-three 
participants met criteria for at least one such psychiatric comorbidity, while twelve had none. 
Two participants had comorbid panic disorder, 9 had generalized anxiety disorder, 17 had social 
anxiety disorder, 7 had major depressive disorder, 2 had dysthymia, 4 had body dysmorphic 
disorder, 1 had post-traumatic stress disorder, 6 had specific phobia and 1 had depressive 
disorder not otherwise specified. Fifteen participants took serotonin-reuptake inhibitors (6 
fluoxetine, 2 escitalopram, 4 sertraline, 2 paroxetine, 1 fluvoxamine), while 29 were 
unmedicated. The medicated individuals did not have any changes in agent or dose for 12 weeks 
prior to enrollment. Fourteen unmedicated OCD individuals took psychiatric medications in the 
past, while sixteen were psychiatric medication-naïve. An IQ <80 on the Wechsler Abbreviated 
Scales of Intelligence (WASI) and medical conditions that affected cerebral metabolism like 
thyroid disorders, diabetes, seizures, brain tumors, a history of stroke, and multiple sclerosis 
were the other exclusion criteria. HCs were recruited via internet ads and flyers. They had no 
psychiatric disorders or substance abuse disorders and no current psychoactive medications or 
major medical conditions. The primary clinical measure for OCD was the Yale-Brown 
Obsessive-Compulsive Scale (YBOCS) [1]. We obtained secondary measures, viz. Montgomery-
Åsberg Depression Rating Scale (MADRS) [2] and Hamilton Anxiety Scale (HAMA) [3]. Social 
and occupational performance and general functionality were rated using the Global Assessment 
Scale (GAS) [4]. 
 
S2. Relationship of the HRF to normal brain function 
To test the relationship of the HRF to normal brain function, we performed a pilot proof of 
concept analysis using handedness, with the hypothesis that the HRF is sensitive to normal brain 
function. This index, the Edinburgh Handedness Scale [5], was acquired for assessment and 
screening purposes in our HC sample and reflects longstanding patterns of motor behavior. 
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Similar to prior studies [6], we determined the relationship between the HRF shape in hand-
movement-related primary motor cortex (MC) regions and handedness. It must be noted that we 
probed this post-hoc, and the study was not initially designed for this; hence, our findings must 
only be considered as preliminary, and for kindling further research on this topic. 
We tested the sensitivity of the HRF to normal brain function with simple testing involving 
motor function in HC. We identified bilateral centroids in the MC using Neurosynth 
(www.neurosynth.org), with the meta-analysis search term “handedness” (centroids in MNI 
space- left MC: -36,-24,58, right MC: 36,-24,58). Instead of using conventional anatomical 
ROIs, Neurosynth was chosen to derive functionally defined ROIs relevant for addressing 
handedness. We defined the regions-of-interest (ROIs) as spheres of radius 5mm around the 
centroids, masked by a 50% gray matter mask. Average fMRI time series were obtained from 
these ROIs, and deconvolution was performed to derive the HRF parameters. The difference in 
HRF parameters was obtained between the right and left MC ROIs, and the association between 
them and percentage right handedness from the Edinburgh Handedness Scale [5] was obtained 
through linear regression separately for each HRF parameter. 
In HC we found a significant association between the difference in HRF RH between right 
and left MC (i.e. HRF RH in right -minus- left MC regions) and percentage right handedness 
(R=-0.57, R2=0.33, P= 0.0028) (Fig.S1). The direction of this association was expected, since 
the Edinburgh Handedness score is an index that is a relative measure of right- vs. left-
handedness. Higher HRF RH in left compared to right MC was associated with higher right-
handedness. Ten out of 13 persons with 100% right handedness exhibited higher HRF RH in the 
left MC compared to the right MC. Among those with less than 100% right-handedness, 8 out of 
12 persons had higher HRF RH in the right MC compared to the left MC. 
We also assessed various quality measures of regression (see section S8) to find that the 
regression did not violate the homoscedasticity assumption (P=0.90, Engle’s ARCH test), and no 
influential observations were found (P<0.018, leave-one-out regressions), although the residuals 
were not uniformly distributed (P=8×10-5, Chi-square goodness-of-fit test) perhaps due to having 
some saturated handedness values. 
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Fig. S1. Association between the difference in response height (RH) of the hemodynamic 
response function (HRF) between right and left primary motor cortices [MC] (i.e. RH in right -
minus- left MC regions) and percentage right handedness. Higher RH in left compared to right 
MC was associated with higher right-handedness. 10 out of 13 persons with 100% right 
handedness had higher RH in the left MC compared to the right MC. Among those with less than 
100% right handedness, 8 out of 12 persons had higher RH in the right MC compared to the left 
MC. R=-0.5715, R2=0.3266, P= 0.0028. 
 
These findings serve as a preliminary proof-of-concept as it was demonstrated on data 
available to us at the time. By no means was this an exhaustive test, but provided a preliminary 
assessment of the sensitivity of HRF to normal brain function. The study sample was comprised 
of all right handers per our inclusion/exclusion criteria, with about half being 100% right handed; 
hence, our observations could be saturated to some extent. Given that this was a pilot test, future 
studies focusing primarily on the healthy brain, are needed to examine possible relationships of 
the HRF shape with other aspects of normal brain functioning. 
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S3. Longitudinal reliability of the HRF 
We assessed test-retest reliability of HRF by quantifying the intra-class correlation (ICC) 
between HRF parameters from scans spaced 4 weeks apart. One of the reasons for us to propose 
the use of the HRF as a marker of brain function and pathology was that the HRF is considered 
to be relatively stable over time [7] [8]. Two sessions of fMRI data were available to us, spaced 4 
weeks apart, for two cases: (i) healthy controls, (ii) a subset of the OCD group (N=21, OCD-
subset group), who had also been scanned 4 weeks prior to the beginning of treatment in addition 
to the pre- and post-CBT scans. We tested the test-retest consistency of the HRF over 4 weeks in 
HCs and the OCD-subset group (4 weeks prior versus onset of treatment) separately by 
computing ICC of HRF RH across the two sessions. We employed the Cronbach’s alpha ICC 
measure (random effects, multiple measurements) [9]. The ICC ranges from -1 to 1, with a 
higher absolute value implying higher stability. 
We found significant brain-wide intra-class correlation between successive scans in HCs 
(r=0.5117, p<0.00001) and in the OCD-subset group (r=0.5063, p<0.00001). These values reflect 
moderate reliability [9]. This provides evidence of moderate stability over time in both healthy 
and pathological populations. It must be noted that the two scans were spaced 4 weeks apart, 
which is long enough for non-pathological routine changes to take place in brain structure and 
chemistry, which might have resulted in some HRF change over these 4 weeks at the individual-
participant level (although no statistically significant changes at the group level were observed, 
as revealed by our analysis presented in main text). Hence, we posit that the test-retest reliability 
of the HRF (i.e. the ICC) would be higher when assessed for scans spaced hours or few days 
apart (open to investigation). These factors could be taken under consideration in future studies 
to assess the suitability of HRF as a marker of brain function and pathology. Aguirre et. al. [8] 
assessed temporal stability of HRF, but only in the central sulcus and only in 4 healthy 
participants, while the current study assessed it at the whole-brain level in a larger cohort. 
 
S4. fALFF analysis 
To compare the HRF against another regional resting-state fMRI measure that is known to be 
sensitive to pathology, we examined the similarities and differences between HRF findings and 
results from a similar analysis using fractional amplitude of low frequency fluctuations (fALFF). 
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Specifically, we compared HRF group difference maps with the group difference maps of 
fALFF. FALFF is a regional measure derived from voxel-level fMRI data, which is widely 
understood and utilized to study brain function [10]. It measures the strength of low frequency 
(0.01-0.1 Hz) fMRI fluctuations, i.e. a measure of resting-state BOLD amplitude. On the other 
hand, HRF RH measures HRF amplitude. Since BOLD power is primarily concentrated in this 
low frequency range, it is not unreasonable to hypothesize that fALFF and RH must both be 
related to the amplitude of neural activity as well as with each other.  
To test this, we computed the voxel-level fALFF Z-score [11], and identified significant 
fALFF differences between Session-1 HC and pre-CBT OCD (statistical methods and thresholds 
identical to HRF analysis). We masked the statistical map with only those regions found to have 
significant differences in RH, TTP and FWHM between Session-1 HC and pre-CBT OCD. We 
did masking because the focus of this study was the HRF, and we performed fALFF analysis 
only to compare with the HRF findings. We then measured the percentage of significant fALFF 
voxels that overlapped (intersection) with the RH group difference map. We did the same for 
TTP and FWHM. We predicted that the fALFF map would exhibit largest similarity with the RH 
map compared to the TTP and FWHM maps. 
We found that the fALFF map had 80.95% overlap with the RH map, 16.67% overlap with 
the TTP map and 7.94% with the FWHM map (note: percentages do not sum to 100 since the 
RH, TTP and FWHM maps themselves had a tiny fraction of common voxels.) Despite 
significant overlap between the RH and fALFF maps, there were no significant associations 
between the two in any of the common voxels, suggesting that HRF RH is distinct from fALFF, 
despite sharing certain biophysical bases.  
As predicted, the fALFF map had highest similarity with the RH map (80.95% overlap), 
likely reflecting common biophysical phenomena underlying these measures. However, RH and 
fALFF were not statistically associated in any of the common voxels, suggesting distinction 
amid seemingly apparent similarities. It remains to be understood what exact relationship these 
two measures share, although conceptually RH is an absolute measurement while fALFF is by 
definition fractional and thus dependent on the amplitude of activations in other frequency bands. 
Low similarity with the TTP and FWHM maps also underscores that these two are distinct from 
measures related to the amplitude of brain activity such as fALFF and RH. In summary, these 
findings lend credence to our prediction that fALFF would be more similar to RH than TTP or 
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FWHM, yet nevertheless show important distinction from RH. These findings help us further 
understand the understudied HRF from the perspective of a widely-used regional measure 
derived from resting-state fMRI, the fALFF. 
Additionally, we performed machine learning prediction analysis for comparison using 
fALFF features, using the procedure identical to the one applied to HRF features (presented in 
main text). We used voxels that exhibited significant fALFF difference for pre-CBT OCD vs 
Session-1 HC comparison (similar to hypothesis-1), and observed an accuracy of 72.39% 
(significantly greater than chance, P<10-30). This accuracy was significantly lower than the 
accuracy of 86.4% obtained using HRF (P<10-30). 
 
 
 
S5. ANOVA results 
Here we present the 2-way ANOVA results performed prior to the pairwise T-tests. We 
performed a 2-way ANOVA with group and time as factors (HC vs OCD and session-1 vs 
session-2), separately for each HRF parameter (p<0.05, cluster-level and FDR thresholded, 
controlled for age, education and head-motion). We found a significant main effect of group 
(Fig.S2a-c) and a significant main effect of time (Fig.S2d-f) with all 3 HRF parameters, and a 
significant group×time interaction with RH and TTP (Fig.S3). 
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Fig. S2. Hemodynamic response function (HRF) findings with the 2-way ANOVA: significant 
main effect of group (HC vs OCD) (a-c), and significant main effect of time (session-1 vs 
session-2) (d-f). (a) Effect of group with response height (RH) of the HRF. (b) Effect of group 
with time-to-peak (TTP) of the HRF. (c) Effect of group with full-width at half-max (FWHM) of 
the HRF. (d) Effect of time with response height (RH) of the HRF. (e) Effect of time with time-to-
peak (TTP) of the HRF. (f) Effect of time with full-width at half-max (FWHM) of the HRF. The 
color bars correspond to the F-values. 
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Fig. S3. Hemodynamic response function (HRF) findings with the 2-way ANOVA: significant 
group×time interaction effect with (a) response height (RH) of the HRF, and (b) time-to-peak 
(TTP) of the HRF. The color bars correspond to the F-values. 
 
 
S6. Effect of medication 
Our OCD group consisted of 15 medicated and 29 unmedicated participants, as described in 
section S1. To assess the effect of medication status on the HRF in this group, we performed two 
analyses, viz. (i) medicated vs. unmedicated participants, and (ii) entire OCD sample (N=44) vs. 
unmedicated participants (N=29). The former comparison was to assess if medicated 
participants’ HRFs differed from unmedicated participants, while the latter comparison was to 
assess how participants with no medications compared with the entire OCD sample used in this 
study. These analyses were performed separately with both session-1 and session-2 data. Since 
our interest was to assess the impact of medication on our HRF findings, and not to identify any 
whole-brain HRF map of the effect of medication, we restricted (masked) the analysis to only 
those regions that emerged significant in our main HRF analysis. We obtained voxel-level maps 
for each of these 12 comparisons, with each voxel having a specific T-value and P-value for the 
corresponding comparison. Here we summarize our findings by reporting the highest T-value 
and lowest P-value among all the tested voxels for each comparison. 
Results showed no significant differences in either of the two tested cases. Specifically, 
medicated and unmedicated participants showed no significant differences at baseline in RH 
(T<1.16, P>0.25), TTP (T<1.09, P>0.28) and FWHM (T<0.94, P>0.35), and after CBT in RH 
(T<1.21, P>0.23), TTP (T<0.99, P>0.33) and FWHM (T<1.12, P>0.27). Likewise, the entire 
OCD sample and unmedicated participants showed no significant differences at baseline in RH 
(T<1.02, P>0.31), TTP (T<1.20, P>0.23) and FWHM (T<1.19, P>0.24), and after CBT in RH 
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(T<0.96, P>0.34), TTP (T<0.89, P>0.38) and FWHM (T<1.14, P>0.26). These observations 
highlight the negligible impact of medication on our HRF findings. 
 
 
S7. Effect of depressive symptoms 
Seven OCD participants had major depressive disorder and 1 had depressive disorder not 
otherwise specified. Among these 8 participants, 6 participants showed reduction in the 
Montgomery-Åsberg Depression Rating Scale (MADRS) [2] from session-1 to session-2 by 
52.2±11.1%, while 2 participants showed increase by 16.7±3.9%. Baseline MADRS values were 
not significantly associated with HRF parameters at baseline in the regions showing significant 
group differences among these 8 participants (P>0.12, median(P)=0.44) nor across the entire 
sample (P>0.17, median(P)=0.75). Likewise, change in MADRS values across sessions were not 
significantly associated with change in HRF parameters across sessions in the regions showing 
significant differences across sessions among these 8 participants (P>0.28, median(P)=0.74) nor 
across the entire sample (P>0.53, median(P)=0.71). From these observations, we can deduce that 
depressive symptoms did not affect our results either at baseline or across sessions in either the 
entire sample or among those with comorbid depressive symptoms. 
 
 
S8. Assessing the quality of regression fits 
In this study, we assessed two associations using linear regression: (i) the association 
between percentage change in HRF RH and percentage change in OCD severity with treatment, 
and (ii) the association between pre-CBT HRF RH and post-treatment OCD severity. Here we 
present certain quality assurance analyses of the regression fits. 
We found significant negative association between (Fig.5a in main text) percentage change 
in HRF RH and percentage change in OCD severity (YBOCS) with CBT treatment (R=-0.44, 
R2=0.19, P=0.0028) in the caudate head region. We plotted the residuals against each variable 
(Fig.S4). We performed the Engle’s ARCH test for residual heteroscedasticity to find that the 
homoscedasticity assumption was not violated (P=0.20). 
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Fig. S4. Plot of the residuals against percentage change in OCD severity with treatment. The 
residuals were determined as the difference between the percentage change in HRF RH values 
and the regression fit as in Fig.5a in the main text. 
 
We also assessed the distribution of residuals to find that the residuals were uniformly 
distributed (P=0.73, Chi-square goodness-of-fit test), and were not Gaussian distributed (P=10-3, 
one-sample Kolmogorov-Smirnov test). We also tested for the presence of influential 
observations by performing leave-one-out regression, i.e. we iteratively repeated the regression 
by discarding exactly one participant (data point) in each iteration (thus performing 44 iterations 
for 44 OCD participants), and assessing if discarding any of the participants resulted in non-
significant associations. If such non-significant associations were to arise then the corresponding 
left out data points would be labeled as influential observations. We found no influential 
observations (R=-0.49 to -0.40; R2=0.16 to 0.24; P=0.0009 to 0.008). 
Next, we found a significant negative association between pre-CBT HRF RH in the caudate 
head and OCD severity (YBOCS) after treatment (R=-0.48, R2=0.23, P= 0.001) (Fig.5b in main 
text). We plotted the residuals against each variable (Fig.S5). We performed the Engle’s ARCH 
test for residual heteroscedasticity to find that the homoscedasticity assumption was not violated 
(P=0.76). 
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Fig. S5. Plot of the residuals against pre-treatment HRF RH in OCD. The residuals were 
determined as the difference between post-treatment OCD severity values and the regression fit 
as in Fig.5b in the main text. 
 
We also assessed the distribution of residuals to find that the residuals were uniformly 
distributed (P=0.14, Chi-square goodness-of-fit test), and were not Gaussian distributed 
(P=4×10-5, one-sample Kolmogorov-Smirnov test). We also tested for the presence of influential 
observations by performing leave-one-out regression, as before. We found no influential 
observations (R=-0.54 to -0.40; R2=0.16 to 0.29; P=0.0002 to 0.0076).  
 
S9. Relationship among the HRF parameters 
Although it is intuitive to associate lower RH with larger TTP or FWHM, it may not always 
be the case. For example, a recent study found lower RH in aging and in those with vascular risk 
but no altered TTP or FWHM in those cases [12]. Likewise, in our study the majority of regions 
showing RH changes were not associated with TTP or FWHM changes. Within our data, we did 
not observe significant correlation across subjects between whole-brain HRF parameters. 
Specifically, in healthy controls, RH and TTP were not significantly correlated (mean R=0.176, 
median P=0.09), nor were RH and FWHM (mean R=0.054, median P=0.46) or TTP and FWHM 
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(mean R=0.145, median P=0.51). In OCD, RH and TTP were not significantly correlated (mean 
R=0.225, median P=0.06), nor were RH and FWHM (mean R=0.055, median P=0.42) or TTP 
and FWHM (mean R=0.136, median P=0.26). RH and TTP seem to be slightly more related than 
RH and FWHM, and even slightly more than TTP and FWHM. Despite these observations, 
based on the underlying biophysics, there is sufficient grounds to hypothesize a direct 
relationship between the HRF parameters in healthy adults, as well as a shift in that relationship 
in brain-related illnesses. Thoroughly addressing these questions is beyond the scope of this 
study, however. Further research is necessary to address these important questions. 
 
S10. Discussion on HRF estimation using resting-state fMRI data 
In this study, we estimated the HRF using resting-state fMRI data using a data-driven 
approach proposed by Wu et al. [13]. An alternative to estimating HRF from resting-state fMRI 
data would be to estimate it from event-related task fMRI data. A major drawback with such an 
approach is that any specific event-related task does not activate the entire brain uniformly [14]; 
different brain regions respond differently to the task events. Also, different tasks elicit different 
patterns of response. Some regions may show the expected pattern of immediate BOLD signal 
increase after an event, while some other regions may show BOLD signal decrease, or even a 
signal decrease in the beginning followed by an increase later. For example, the study by 
Gonzalez-Castillo et al. found a prolonged dip in the hemodynamic response in certain prefrontal 
regions during a simple event-related visual task, which is completely uncharacteristic of the 
canonical HRF shape [7] [8]. Despite these challenges, another recent study tried to estimate the 
HRF from event-related task fMRI data [15] and found that even a simple task that was expected 
to activate the majority of the brain was able to activate only 77% of the gray matter voxels; 
additionally, similar observations of negative hemodynamic responses as well as hemodynamic 
responses of strange shapes were observed in activated voxels. In this context, it is important to 
recognize that the HRF is different from a “hemodynamic response”; the HRF is a transfer 
function linking neural activity to local blood flow, while a “hemodynamic response” is the 
measured fMRI response to a task. 
It thus appears problematic to use event-related task fMRI to estimate the HRF for the 
purpose of understanding brain function (or pathology and treatment response) for two reasons: 
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(i) whole-brain HRF cannot be estimated in every voxel using the events from the task because 
any given task is unlikely to activate the whole brain. (ii) Even among activated voxels, the 
hemodynamic response to the task events may be non-uniform. The definition of the HRF is 
violated if negative or strange shape HRFs are estimated – the HRF is the hemodynamic 
response in the local blood vessel to a unit neural event in the nearby neurons, which has been 
shown to always have a shape similar to a double-gamma function [16] [17]. For example, a 
negative hemodynamic response may be observed due to a dip in neural activity during a task, 
yet the HRF is still positive (note the distinction between the measured hemodynamic response 
and the HRF here). Consistent with invasive electrophysiological evidence [18], the HRF 
typically has an initial ascent following the event, a maximum response (response height) that 
occurs sometime after the event (time-to-peak), a descent, a post-stimulus undershoot and a 
return to baseline (refer to Fig.2 in main text). For these reasons, extremely few studies have 
attempted to study HRFs estimated from event-related task fMRI data, and a majority of the 
literature on HRF is based on those estimated from resting-state fMRI data. HRF estimation 
using resting-state fMRI data using Wu et al’s technique [13] does not face these shortcomings 
because the pseudoevents are identified in a data-driven fashion using large BOLD events in the 
time series that resemble the characteristic HRF shape; and, since the pseudoevents are not based 
on any specific task, we can estimate HRF across the whole brain. These are among the factors 
that motivated us to estimate whole-brain HRF in this study using resting-state fMRI data, as in 
previous studies [19] [13] [20] [21] [22] [23] [24] [25]. 
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